Horizon Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.22M Buy
+9,713
New +$1.22M 0.02% 520
2024
Q4
Sell
-16
Closed -$1.84K 905
2024
Q3
$1.84K Buy
16
+6
+60% +$692 ﹤0.01% 708
2024
Q2
$1.38K Hold
10
﹤0.01% 719
2024
Q1
$1.38K Buy
10
+6
+150% +$827 ﹤0.01% 703
2023
Q4
$527 Buy
+4
New +$527 ﹤0.01% 724